The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

In a move that is widely seen as a step in the right direction for consumer safety, a consortium of pharmaceutical companies and academic institutions will combine forces to study data concerning the link between genetics and drug safety. The pharmaceutical companies involved in the group include: Abbott Laboratories, GlaxoSmithKline PLC, Johnson & Johnson, Pfizer Inc., Roche Holding AG, Sanofi-Aventis SA and Wyeth. The initial collaboration will study Stevens-Johnson Syndrome which manifests itself with a painful, blistering skin rash. The syndrome can be fatal if the person is exposed to a drug that initially caused the Syndrome. These studies may be used by the FDA to improve drug safety and monitoring techniques. It’s definately the right move to protect consumers.

Comments are closed.

Of Interest